Akebia Therapeutics (AKBA) Invested Capital (2018 - 2026)
Akebia Therapeutics (AKBA) posted quarterly Invested Capital of $12.5 million for Q1 2026, down 28.6% quarter-over-quarter from $17.5 million in Q4 2023.
Akebia Therapeutics (AKBA) Invested Capital (2018 - 2026) Analysis & Trends
Akebia Therapeutics (AKBA) has reported Invested Capital for 5 consecutive years, with $12.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Invested Capital changed N/A year-over-year to $12.5 million; the TTM figure through Mar 2026 stood at $12.5 million (changed N/A YoY), while the FY2023 annual figure was $17.5 million, down 45.31% from the prior year.
- Invested Capital fell to $12.5 million in Q1 2026 per AKBA's latest filing, from $17.5 million in the prior quarter.
- Across five years, Invested Capital topped out at $98.2 million in Q2 2022 and bottomed at $8.0 million in Q3 2023.
- Historically, Invested Capital has averaged $42.2 million across 3 years, with a median of $24.0 million in 2023.
- On a YoY basis, Invested Capital climbed as much as 45.31% in 2023 and fell as far as 87.87% in 2023.
- Akebia Therapeutics' Invested Capital stood at $32.0 million in 2022, then sank by 45.31% to $17.5 million in 2023, then declined by 28.6% to $12.5 million in 2026.
- Business Quant data shows AKBA's Invested Capital at $12.5 million in Q1 2026, $17.5 million in Q4 2023, and $8.0 million in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 630.00 Mn |
| 10 | Akebia Therapeutics | 247.98 Mn | 92.43 Mn | 38.70 Mn | 24.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.81 Mn |
| Mar 31, 2026 | 12.50 Mn |
| Dec 31, 2023 | 17.50 Mn |
| Sep 30, 2023 | 8.00 Mn |
| Jun 30, 2023 | 24.00 Mn |
| Mar 31, 2023 | 24.00 Mn |
| Dec 31, 2022 | 32.00 Mn |
| Sep 30, 2022 | 65.95 Mn |
| Jun 30, 2022 | 98.16 Mn |
| Mar 31, 2022 | 97.85 Mn |
| Dec 31, 2021 | 97.54 Mn |
| Dec 31, 2018 | 15.00 Mn |